In late August, Johnson & Johnson was hit with a $572 million judgment for its role in the opioid crisis following a bench trial in Oklahoma. This week, the ClaimsCoach offers seven “hot takes” with regard to the insurance, risk management and legal strategy implications of this case.
What was the surprising reaction of the investment community?
As a bellwether case, what does the Oklahoma trial say for J&J’s future defense efforts?
How likely is it that insurance coverage will come into play?
What does the Oklahoma trial outcome portend with regard to the “deterrence theory” of litigating cases in order to discourage future claims?
These and other issues Kevin spotlights, issues that have implications for claim professionals managing other types of repetitive claims — mass tort claims, class actions and multidistrict litigation.